Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug ...

In Alzheimer’s disease, BioVie has conducted both Phase 2 and Phase 3 trials. Early results suggest improvements in cognition and biomarkers, supporting further trials to evaluate its potential as a ...

University of Arizona researchers have revealed new insights into the neurobiological cause of the involuntary, uncontrollable movement disorders that develop in patients with Parkinson’s disease (PD) ...

Explore Duopa, an advanced Parkinson's disease treatment that uses carbidopa-levodopa gel infusion for steady dopamine levels, reducing motor fluctuations effectively.

CREXONT ® is a novel, oral formulation of carbidopa/levodopa (CD/LD) capsule that combines both immediate-release granules and extended-release beads for the treatment of Parkinson’s disease. CREXONT ...

Medically reviewed by Nicholas R. Metrus, MD Key Takeaways Akinesia is a condition where you cannot make voluntary movements, ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new insights ...

Duopa (carbidopa/levodopa) may not be safe to take while pregnant or breastfeeding. It’s not known whether Duopa causes fetal harm. Talk with your doctor to determine what treatment is appropriate for ...

The FDA extended its decision date for investigational tolebrutinib in non-relapsing, secondary progressive multiple sclerosis (MS) to December 28, Sanofi said. The agency also opted to not approve ...